Abstract

Iron acquisition pathways have often been considered to be gateways for the uptake of antibiotics into bacteria. Bacteria excrete chelators, called siderophores, to access iron. Antibiotic molecules can be covalently attached to siderophores for their transport into pathogens during the iron-uptake process. P. aeruginosa produces two siderophores and is also able to use many siderophores produced by other bacteria. We investigated the phenotypic plasticity of iron-uptake pathway expression in an epithelial cell infection assay in the presence of two different siderophore–antibiotic conjugates, one with a hydroxamate siderophore and the second with a tris-catechol. Proteomic and RT-qPCR approaches showed that P. aeruginosa was able to sense the presence of both compounds in its environment and adapt the expression of its iron uptake pathways to access iron via them. Moreover, the catechol-type siderophore–antibiotic was clearly more efficient in inducing the expression of its corresponding transporter than the hydroxamate compound when both were simultaneously present. In parallel, the expression of the proteins of the two iron uptake pathways using siderophores produced by P. aeruginosa was significantly repressed in the presence of both conjugates. Altogether, the data indicate that catechol-type siderophores are more promising vectors for antibiotic vectorization using a Trojan-horse strategy.

Highlights

  • Antibiotic resistance is a complex and growing problem for human health

  • Antibiotics can be covalently linked to siderophores with the idea that they will be transported into the pathogens during the ferri-siderophore uptake process—referred to as a Trojan-horse strategy [1,4,5]

  • The efficient uptake of siderophore–antibiotic conjugates into bacteria requires that various conditions be met

Read more

Summary

Introduction

Antibiotic resistance is a complex and growing problem for human health. In 2017, the World Health Organization published a list of highly resistant bacteria for which new antibiotics are urgently needed. Bacteria produce siderophores, small molecules with a very high affinity for ferric iron [2]. Antibiotics can be covalently linked to siderophores with the idea that they will be transported into the pathogens during the ferri-siderophore uptake process—referred to as a Trojan-horse strategy [1,4,5]. One such siderophore–antibiotic conjugate (Cefiderocol), developed by Shionogi, was approved by the US Food and Drug Administration (FAD) in November 2019 for the treatment of complicated urinary tract infections, showing that Trojan-horse strategies can be successful [6]. The archetypes among sideromycins are albomycins [7,8], ferrimycins [9], danomycins [10], and salmycins [11], isolated mainly from streptomycetes or actinomycetes and produced to kill other microorganisms and dominate a given microbiota

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call